TD-4208

TD-4208 · Mylan Inc.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for TD-4208, covering 2016-12-07 to 2019-11-14. Get the full timeline:

Most recent: Clinical Trial Update: Effects of TD-4208 on FEV1 in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]